Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 15Breast 10Head & Neck 6Genitourinary 4Sarcoma 3Gynecologic 3Endocrine 3Tumor-Agnostic 2NET 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Lymphoid 1

Conditions

Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liquid Biopsy × Tumor-Agnostic × Clear all
NCT06287749 2025-07-10

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

University Hospital, Montpellier

Recruiting
37 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT05283044 2025-06-25

PRISM-POrTAL

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Recruiting
10,000 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡